Association of p53 Arg72Pro polymorphism and β-catenin accumulation in mycosis fungoides

British Journal of Dermatology

Volumn 155, Issue 6, 2006, Pages 1223-1229

  Bellei, B ^a   Cota, C ^a   Amantea, A ^a   Muscardin, L ^a   Picardo, M ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

catenin; Apoptosis; Cutaneous T cell lymphoma; Mycosis fungoides; p53; Polymorphism

Indexed keywords

ARGININE; BETA CATENIN; DNA; PROLINE; PROTEIN P53; PROTEIN P63;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA EXTRACTION; DNA ISOLATION; EXON; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICROBEAM MICRODISSECTION; MALE; MUTATIONAL ANALYSIS; MYCOSIS FUNGOIDES; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; STRUCTURAL HOMOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CODON; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; POLYMORPHISM, GENETIC; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33750924623     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07527.x     Document Type: Article

References (32)

1. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993; 9:317-21.
2. Ben-Ze'ev A, Geiger B. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 1998; 10:629-39.
3. Cox RT, Peifer M. Wingless signaling: the inconvenient complexities of life. Curr Biol 1998; 8:R140-4.
4. Willert K, Nusse R. β-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998; 8:95-102.
5. Polakis P. Wnt signaling and cancer. Genes Dev 2002; 14:1837-51.
6. Liu C, Li Y, Semenov M et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002; 108:837-47.
7. Rubinfeld B, Albert I, Porfiri E et al. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6.
8. Morin PJ, Sparks AB, Korinek V et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275:1787-9.
9. Polakis P. The oncogenic activation of β-catenin. Curr Opin Genet Dev 1999; 9:15-21.
10. Jaiswal AS, Balusu R, Narayan S. Involvement of adenomatous polyposis coli in colorectal tumorigenesis. Front Biosci 2005; 10:1118-34.
11. Voller HJ, Truica CI, Gelmann EP. β-catenin mutations in human prostate cancer. Cancer Res 1998; 58:2520-3.
12. Chan EF, Gat U, McNiff M, Fuchs E. A common human skin tumor is caused by activating mutations in β-catenin. Nat Genet 1999; 21:410-14.
13. de La Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95:8847-51.
14. Candidus S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996; 56:49-52.
15. Rimm DL, Kaka K, Hu G et al. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 1999; 154:325-9.
16. Lin SY, Xia W, Wang JC. Beta-catenin, a novel prognostic marker for breast cancer: its role in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000; 97:4262-6.
17. Ueda M, Gemmill RM, West J. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001; 85:64-8.
18. Shinohara A, Yokoyama Y, Wan X. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol 2001; 82:450-5.
19. Bellei B, Pacchairotti A, Perez M, Faraggiana T. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas. Mod Pathol 2004; 17:1275-81.
20. Damalas A, Ben-Ze'ev A, Simcha I. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 2001; 20:4912-22.
21. Cagatay T, Ozturk M. p53 mutation as a source of aberrant β-catenin accumulation in cancer cells. Oncogene 2001; 21:7971-80.
22. Watcharasit P, Bijur GN, Song L et al. Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53. J Biol Chem 2003; 278:48872-9.
23. Patturajan M, Nomoto S, Sommer M. ΔNp63 induces β-catenin nuclear accumulation and signaling. Cancer Cell 2002; 1:369-79.
24. Reis-Filho JS, Simpson PT, Fulford LG et al. p63-driven nuclear accumulation of β-catenin is not a frequent event in human neoplasms. Pathol Res Pract 2003; 199:785-93.
25. Kapur S, Menke MAON, Tiemann M et al. Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression. J Dermatol Sci 2001; 26:36-45.
26. Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutation but no Bax or p53 mutation in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002; 118:949-56.
27. Beckman G, Birgander R, Sjalander A et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994; 44:266-70.
28. Thomas M, Kalita A, Labreque S et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19:1092-100.
29. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108:196-9.
30. Bonafè M, Salvioli S, Barbi C et al. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischemia-induced cell death. Cell Death Differ 2004; 11:962-73.
31. Sullivan A, Syed N, Gasco M. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 2004; 23:3328-37.
32. Wang J, Shou J, Chen X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 2000; 19:1843-8.